Calvin Stiller heads up Genome Canada board

Guest Contributor
September 2, 2005

Calvin Stiller has been appointed chair of Genome Canada’s board of directors. Stiller is the former chair and CEO of the Canadian Medical Discoveries Fund, a co-founder of four other venture capital funds and a medical pioneer in the area of xenotransplantation.

Stiller assumes the chair position of a board with several new members. They include:

* Thomas Hudson (vice-chair), McGill Univ & Genome Quebec Innovation Centre;

* Natalie Dakers, CEO, Centre of Drug Research & Development (British Columbia);

* Connie Eaves, professor of medicine, Univ of British Columbia,;

* Kelvin Ogilvie, professor of chemistry, Acadia Univ;

* Jacques Simard, director, Cancer Genomics Laboratory, CHUQ/CHUL Research Centre; and,

* Ronald Worton, CEO and scientific director, Ottawa Health Research Institute.


Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.